The COVID-19 pandemic has wreaked havoc globally, including in Indonesia. It has claimed many lives, increased the health burden, and weakened economic .
The National Research and Innovation Agency (BRIN) has encouraged stem cell research in the country by developing the capacity of human resources, research .
Head of the Biological Sciences Research Organization (OR IPH) of the National Research and Innovation Agency (BRIN), Iman Hidayat, has estimated that only 10 .
A recent announcement that the Red and White vaccine is expected to be ready for production by mid-2022 offers hope to Indonesians who have been waiting for a .
Development of the Red and White vaccine to handle COVID-19 remains a priority in the National Research and Innovation Agency's research and innovation .